Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02700932
Other study ID # DHF20901
Secondary ID
Status Active, not recruiting
Phase N/A
First received February 23, 2016
Last updated April 3, 2017
Start date January 20, 2016
Est. completion date December 2017

Study information

Verified date April 2017
Source Syneron Medical
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an open-label, multi-center study. Subjects in this study will receive up to eight (8) treatments in 11±5 weeks (6-16 weeks) interval, with the PicoWayTM device using the 1064 nm/ 785±20 nm/ 532 nm handpiece according to the study protocol (tattoo colors). Subjects will return for one follow‐up (FU) visit at the clinic at 8 weeks following the last treatment.

Methodology described in the protocol to evaluate efficacy and safety of treatments will be carried out at each visit at the clinic


Description:

This study is a prospective clinical study to demonstrate the safety and efficacy of the PicoWayTM device for tattoo removal.

Up to a total of 60 healthy candidates who are seeking tattoo removal clearance treatment from participating investigators will be enrolled at up to 3 participating study sites. Subjects will receive up to eight (8) PicoWayTM treatments at 11±5 (6-16) week's intervals. Prior to each consecutive treatment, the investigator will decide, based on degree of clearance assessment, should the subject undergo additional treatment or to be forwarded to the 8 weeks Follow-Up visit with no more treatments. Topical anesthetic (ointment) or intradermal injected solution may be used prior to treatment.

Each subject will be followed at one post treatment visit that will be conducted at:

• Eight weeks post last treatment - 8wk FU.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 15
Est. completion date December 2017
Est. primary completion date September 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

1. Healthy female and male subjects between 18 to 70 years of age

2. Fitzpatrick skin type I-VI

3. Have unwanted decorative (non-cosmetic) tattoo(s) and willing to undergo laser treatments to remove them

4. Have at least one of the following colors in the tattoo: black, green and\ or blue.

5. Willing to receive the proposed PicoWayTM treatments and comply with all study (protocol) requirements

6. Willing to have photographs and images taken of the treated areas to be used in evaluations, publications and presentations (subject identity will be masked)

7. For female subjects: not pregnant or lactating and is either post-menopausal, surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment (i.e., oral contraceptives, contraceptive implant, barrier methods with spermicide or abstinence)

8. Informed consent process is completed and subject consent is signed

Exclusion Criteria:

1. Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding

2. Hypersensitivity to light exposure

3. Active sun tan

4. Suffering from significant skin conditions in the treated areas or inflammatory skin conditions, including, but not limited to, open lacerations or abrasions, hidradenitis, or dermatitis of the treatment area prior to treatment (duration of resolution as per the Investigator's discretion) or during the treatment course

5. Have a history of squamous cell carcinoma or melanoma

6. History of keloid scarring, abnormal wound healing and / or prone to bruising

7. Use of oral isotretinoin (Accutane®) within 12 months of initial treatment or plans on using during the course of the study. Note: Skin must regain its normal degree of moisture prior to treatment, e.g., lack of noticeable skin flaking, skin peeling and skin surface roughness.

8. History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications

9. Known allergy to lidocaine, tetracaine, Xylocaine or epinephrine

10. As per the investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PicoWay
solid state laser capable of delivering energy at wavelengths of 1064 nm or 532 nm or wave length of 785±20 nm that was added to the system

Locations

Country Name City State
United States Main Line Center for Laser Surgery Ardmore Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Syneron Medical

Country where clinical trial is conducted

United States, 

References & Publications (2)

Bernstein EF, Schomacker KT, Basilavecchio LD, Plugis JM, Bhawalkar JD. A novel dual-wavelength, Nd:YAG, picosecond-domain laser safely and effectively removes multicolor tattoos. Lasers Surg Med. 2015 Jul 14. doi: 10.1002/lsm.22391. [Epub ahead of print] — View Citation

Saedi N, Metelitsa A, Petrell K, Arndt KA, Dover JS. Treatment of tattoos with a picosecond alexandrite laser: a prospective trial. Arch Dermatol. 2012 Dec;148(12):1360-3. doi: 10.1001/archdermatol.2012.2894. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Global percentage of tattoo clearance Global percentage of tattoo clearance as assessed by blinded evaluators based on comparing pre and post treatment photos. 8 weeks post final treatment
Secondary Rate of tattoo clearance Average number of treatments determined to achieve 50 and 75 percent clearance 8 weeks post final treatment
Secondary Adverse event reporting Based on rate and severity of treatments with the PicoWay laser treatment Through study completion, average of 1 year
See also
  Status Clinical Trial Phase
Terminated NCT03415685 - Lutronic PicoPlus Exploratory Clinical Trial N/A
Active, not recruiting NCT05248009 - Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy N/A
Recruiting NCT03386760 - Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos Phase 1/Phase 2
Recruiting NCT06431464 - Tattoo Particles: Picosecond Laser Versus Nanosecond Laser
Completed NCT05877833 - Evaluating the Safety and Performance Characteristics of Ephemeral® Tattoo Ink in Healthy Subjects
Completed NCT03640819 - Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer N/A